Skip to main content

Inspection visit

Health inspection

WINDSOR NURSING AND REHABILITATION CENTER OF DUVALCMS #6759561 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0756 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interviews and record review the facility failed to act upon the pharmacist's drug regimen review irregularity reports for two of (Residents #1 and #2) of seven residents reviewed for medication consents. 1. The facility failed to respond to the pharmacist's notification that Resident #1's Trazodone (an antidepressant and sedative medication used to treat depression and may also be used for other conditions) consent was missing and needed to be obtained and uploaded. The facility had an unsigned written consent from Resident #1's RP before administering Trazodone. 2. The facility failed to respond to the pharmacist's notification that Resident #2's Lorazepam (a medication used to treat anxiety) consent was missing and needed to be obtained and uploaded. The facility had an unsigned written consent from Resident #2's RP before administering Lorazepam. This failure could place residents at risk of not having their preferred RP represent them in medical and care decisions, their preferred RP being unaware of the care, treatment, and treatment alternatives they are being provided, and not having pharmacist's notifications and recommendations for their medications and treatments followed. Findings included: Resident #1 Review of Resident #1's admission record, dated 09/19/24, reflected a [AGE] year-old female who was admitted to the facility on [DATE], had a POA/RP , and with diagnoses including burns involving 20-29% of body surface with 0%-9% third degree burns, bipolar disorder current episode depressed mild or moderate severity unspecified, generalized anxiety disorder, and cognitive communication deficit. Review of Resident #1's quarterly MDS, dated [DATE], reflected a BIMS score of 3, indicating she had severe cognitive impairment. Section N (Medications) reflected Resident #1 was receiving an antipsychotic and antidepressant. Review of Resident #1's quarterly care plan, dated 08/19/24, reflected she had a mood problem related to bipolar disorder, anxiety, and history of alcohol abuse with an intervention to monitor, record, and/or report to MD as needed any signs or symptoms of depression, anxiety, or sad mood. Resident #1's care plan also reflected she used antipsychotic medications (Seroquel) related to bipolar disorder with an intervention to monitor/document/report as needed any adverse reactions of antipsychotic medications, such as insomnia. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 675956 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 675956 B. Wing A. Building (X3) DATE SURVEY COMPLETED 09/19/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Windsor Nursing and Rehabilitation Center of Duval 5301 W Duval Rd Austin, TX 78727 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Review of Resident #1's order summary report, dated 09/19/24, reflected an active order started on 06/10/24 for the following: Trazodone HCI Oral Tablet 50 MG (Trazodone HCI) Give 0.5 tablet by mouth at bedtime for insomnia (give 25mg). Review of Resident #1's electronic health records, as of 09/19/24, reflected there was no consent form for her Trazodone HCI Oral Tablet 50 MG (Trazodone HCI) order. Review of Resident #1's MAR schedule for August and September 2024 reflected she received the Trazodone order from 08/01/24 through 09/18/24 . Resident #2 Review of Resident #2's admission record, dated 09/19/24, reflected a [AGE] year-old female who was admitted to the facility on [DATE], had an RP, and with diagnoses including paranoid schizophrenia and unspecified dementia. Review of Resident #2's quarterly MDS, dated [DATE], reflected no BIMS score indicated. Section N (Medications) reflected Resident #1 was receiving an antidepressant. Review of Resident #2's quarterly care plan, dated 08/27/24, reflected she had the potential to be verbally aggressive related to dementia and mental/emotional illness. Review of Resident #2's order summary report, dated 09/19/24, reflected she completed the following order started on 08/22/24 and ended on 09/05/24: Lorazepam (Ativan) 0.5MG/ML GEL 0.5 mg/1ml MG/ML (Lorazepam) Apply 0.5 mg transdermally every 8 hours as needed for anxiety/agitation for 14 Days. Review of Resident #2's Informed Consent for Psychoactive Medications, undated, reflected an order for Lorazepam Gel for acute agitation and anxiety. Resident #2 printed her name on the consent 08/22/24 and did not sign. RP printed their name on 08/22/24 and did not sign. Facility representative who provided information and completed the consent form signed on 08/22/24 . Review of Resident #2's MAR schedule for August and September 2024 reflected she did not receive the Lorazepam order from 08/01/24 through 09/18/24 . Review of the facility's Pharmacist Review from June through August 2024 reflected the Pharmacist initiated a medication regimen review on 06/17/24 and indicated Resident #1's Trazodone consent was unable to be located and recommended staff to obtain and scan consent into the chart. The Pharmacist also initiated a medication regimen review on 08/26/24 and indicated Resident #2's Lorazepam consent was unable to be located and recommended staff to obtain and scan consent into the chart. During an interview on 09/19/24 at 1:23 p.m., the NP stated consents must be signed by residents' POAs . During an interview on 09/19/24 at 2:39 p.m., the ADON stated her expectations for psychological consents were that they were to be signed right away from pen to paper. The ADON stated consents must be signed by the resident or the resident's RP. The ADON stated it was important to have consents signed so staff had consent to treat the resident using medications. The ADON stated the receiving (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 675956 If continuation sheet Page 2 of 3 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 675956 B. Wing A. Building (X3) DATE SURVEY COMPLETED 09/19/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Windsor Nursing and Rehabilitation Center of Duval 5301 W Duval Rd Austin, TX 78727 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756 Level of Harm - Minimal harm or potential for actual harm nurse was responsible for getting residents' consents signed. The ADON stated her, and the DON's job were to oversee and make sure residents' consents were completed . Review of the facility's Notification of Changes policy and procedure, implemented 10/24/22, reflected the following: Residents Affected - Few The facility must inform the resident, consult with the resident's physician and /or notify the resident's family member or legal representative when there is a change requiring such notification. Circumstances requiring notification include: 3. Circumstances that require a need to alter treatment. This may include: a. New treatment. Additional considerations: 2. Residents incapable of making decisions: a. The representative would make any decisions that have to be made. b. The resident should still be told what is happening go him or her. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 675956 If continuation sheet Page 3 of 3

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0756GeneralS&S Dpotential for harm

    F756 - Drug Regimen Review

    Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.

FAQ · About this visit

Common questions about this visit

What happened during the September 19, 2024 survey of WINDSOR NURSING AND REHABILITATION CENTER OF DUVAL?

This was a inspection survey of WINDSOR NURSING AND REHABILITATION CENTER OF DUVAL on September 19, 2024. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at WINDSOR NURSING AND REHABILITATION CENTER OF DUVAL on September 19, 2024?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity ..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.